Evidence map›Paper›PMID 30835508›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2019

Energy metabolism couples hepatocyte integrin-linked kinase to liver glucoregulation and postabsorptive responses of mice in an age-dependent manner.

Elijah Trefts, Curtis C Hughey, Louise Lantier, Dan S Lark, Kelli L Boyd, Ambra Pozzi, Roy Zent, David H Wasserman

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Elijah TreftsDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.
Curtis C HugheyDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.
Louise LantierDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.ORCID 0000-0002-6620-4976
Dan S LarkDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.ORCID 0000-0001-8386-8478
Kelli L BoydDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine , Nashville, Tennessee.
Ambra PozziDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.
Roy ZentDepartment of Medicine, Vanderbilt University School of Medicine , Nashville, Tennessee.
David H WassermanDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine , Nashville, Tennessee.
Vanderbilt University · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
INTEGRATED CONTROL OF MUSCLE GLUCOSE UPTAKE IN VIVOR01DK054902 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 1999 to 2020
$5.9M
Vanderbilt O'Brien Kidney Center - Core D - Clinical and Translational CoreP30DK114809 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DE CAESTECKER, MARK P. · 2017 to 2021
$5.9M
Role of the Cell Adhesome in Obesity-related Liver DiseasesR01DK050277 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1995 to 2023
$4.8M
Exercise and Fuel MetabolismR37DK050277 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2008 to 2017
$4.2M
The P450 Epoxygenases as Pro-Oncogenic EnzymesR01CA162433 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI POZZI, AMBRA · 2012 to 2016
$1.9M
Matrix receptors in chronic kidney diseaseR01DK119212 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BORZA, CORINA MARILENA, POZZI, AMBRA · 2018 to 2022
$1.7M
Integrin/TGF-beta Axis in Tubulointerstitial FibrosisR01DK095761 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI POZZI, AMBRA · 2013 to 2016
$1.4M
BLRD VA I01 BX002025BLRD VA I01 BX002196NCI NIH HHS R01 CA162433NIDDK NIH HHS F31 DK112553NIDDK NIH HHS L40 DK069221NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30 DK114809NIDDK NIH HHS R01 DK050277NIDDK NIH HHS R01 DK054902NIDDK NIH HHS R01 DK083187NIDDK NIH HHS R01 DK095761NIDDK NIH HHS R01 DK119212NIDDK NIH HHS R37 DK050277NIDDK NIH HHS R56 DK054902NIDDK NIH HHS T32 DK007563NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U2C DK059637
6 · The paper itself

Abstract

Integrin-linked kinase (ILK) is a critical intracellular signaling node for integrin receptors. Its role in liver development is complex, as ILK deletion at E10.5 (before hepatocyte differentiation) results in biochemical and morphological differences that resolve as mice age. Nevertheless, mice with ILK depleted specifically in hepatocytes are protected from the hepatic insulin resistance during obesity. Despite the potential importance of hepatocyte ILK to metabolic health, it is unknown how ILK controls hepatic metabolism or glucoregulation. The present study tested the role of ILK in hepatic metabolism and glucoregulation by deleting it specifically in hepatocytes, using a cre-lox system that begins expression at E15.5 (after initiation of hepatocyte differentiation). These mice develop the most severe morphological and glucoregulatory abnormalities at 6 wk, but these gradually resolve with age. After identifying when the deletion of ILK caused a severe metabolic phenotype, in depth studies were performed at this time point to define the metabolic programs that coordinate control of glucoregulation that are regulated by ILK. We show that 6-wk-old ILK-deficient mice have higher glucose tolerance and decreased net glycogen synthesis. Additionally, ILK was shown to be necessary for transcription of mitochondrial-related genes, oxidative metabolism, and maintenance of cellular energy status. Thus, ILK is required for maintaining hepatic transcriptional and metabolic programs that sustain oxidative metabolism, which are required for hepatic maintenance of glucose homeostasis.

Indexed as

Insulin ResistanceAge FactorsAnimalsBlood GlucoseCell DifferentiationCell RespirationEnergy MetabolismGene Knockout TechniquesGlucoseGlucose Tolerance TestHepatocytesHomeostasisInflammationInsulinLiverLiver CirrhosisBlood GlucoseGlucoseInsulinProtein Serine-Threonine KinasesScaffold Protein ILKglucose homeostasisglycogen metabolismhepatocyte signalingintegrin signalingin vivo physiologyliver metabolism

Identifiers

PMID30835508
PMCPMC6732653
OpenAlexW2918679997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.